Samples available at no cost

Receive INTRAROSA samples, at no cost, for your appropriate postmenopausal patients with moderate to severe dyspareunia. No patient, pharmacy, or payer should be billed for the sample product supplied. Subject to availability.

Please download and submit one unique form per sample request.

Indication

INTRAROSA is a steroid indicated for the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause.

Important Safety Information

INTRAROSA is contraindicated in women with undiagnosed abnormal genital bleeding.

Estrogen is a metabolite of prasterone. Use of exogenous estrogen is contraindicated in women with a known or suspected history of breast
cancer. INTRAROSA has not been studied in women with a history of breast cancer.

In four 12-week randomized, placebo-controlled clinical trials, the most common adverse reaction with an incidence ≥2 percent was vaginal discharge. In one 52-week open-label clinical trial, the most common adverse reactions with an incidence ≥2
percent were vaginal discharge and abnormal Pap smear.